COMPOSITIONS AND METHODS FOR POTENTIATING DERIVATIVES OF 4-AMINOPHENOLS
The present disclosure provides pharmaceutical compositions and methods for treating paracetamol amenable conditions, such as pain and fever. The pharmaceutical compositions comprise certain combinations of derivatives of 4-Aminophenols and N-acylethanolamines. Also disclosed are methods and kits for treating or minimizing paracetamol amenable conditions.
1 . A pharmaceutical composition comprising a therapeutically-effective amount of a mixture of at least one derivative of 4-Aminophenol or a salt thereof and at least one N-acylethanolamine or a salt thereof.
2 . The pharmaceutical composition of claim 1 , comprising about 0.5 mg to about 4000 mg of the at least one derivative of 4-Aminophenol or salt thereof.
3 . The pharmaceutical composition of claim 1 , wherein the at least one derivative of 4-Aminophenol is paracetamol.
4 . The pharmaceutical composition of claim 3 , wherein the pharmaceutical composition comprises about 10 mg, about 48 mg, about 80 mg, about 120 mg, about 160 mg, about 325 mg, about 500 mg, or about 650 mg of the paracetamol.
5 . The pharmaceutical composition of claim 1 , wherein the pharmaceutical composition comprises about 800 mg of the N-acylethanolamine or salt thereof.
6 . The pharmaceutical composition of claim 1 , wherein the at least one N-acylethanolamine is chosen from N-palmitoylethanolamine (PEA), Me-Palmitoylethanolamide (Me-PEA), palmitoylcyclohexamide, palmitoylbutylamide, palmitoylisopropylamide, oleoylethanolamine (OEA), palmitoylisopropylamide (PIA), salts thereof, and any combination thereof.
7 . The pharmaceutical composition of claim 6 , wherein the at least one N-acylethanolamine is PEA or salt thereof.
8 . The pharmaceutical composition of claim 1 , wherein the mixture comprises paracetamol or a salt thereof and PEA or a salt thereof.
9 . The pharmaceutical composition of claim 8 , wherein the mixture comprises about 0.5 mg to about 4000 mg of the paracetamol or salt thereof and about 50 mg to about 5000 mg of the PEA or salt thereof.
10 . The pharmaceutical composition of claim 1 , wherein the pharmaceutical composition is formulated for systemic administration.
11 . The pharmaceutical composition of claim 10 , wherein the pharmaceutical composition is formulated for oral, vaginal, rectal, oral mucosal, nasal, sublingual, inhalational, topical, parenteral, intravenous, intramuscular, or subcutaneous administration.
12 . (canceled)
13 . The pharmaceutical composition of claim 1 , wherein the pharmaceutical composition is formulated as a solution or as a suppository.
14 . A dosage unit comprising the pharmaceutical composition of claim 1 .
15 . A method for treating pain or fever in a subject in need thereof comprising administering to the subject the pharmaceutical composition of claim 1 .
16 . The pharmaceutical composition of claim 15 , wherein the pain is chosen from an acute pain, chronic pain, and neuropathic pain.
17 . A method for treating at least one side-effect associated with paracetamol consumption comprising administering to the subject the pharmaceutical composition of claim 1 .
18 - 19 . (canceled)
20 . A method of treating pain or fever comprising:
administering to a subject in need thereof a therapeutically-effective amount of at least one derivative of 4-Aminophenol or salt thereof; and
administering to the subject a therapeutically-effective amount of at least one N-acylethanolamine or a salt thereof.
21 . The method of claim 20 , wherein the therapeutically-effective amount of the at least one derivative of 4-Aminophenol or salt thereof is from about 0.5 mg to about 4000 mg.
22 . The method of claim 20 , wherein the at least one derivative of 4-Aminophenol is paracetamol.
23 . The method of claim 22 , wherein the therapeutically-effective amount of paracetamol is about 10 mg, about 48 mg, about 80 mg, about 120 mg, about 160 mg, about 325 mg, about 500 mg, or about 650 mg.
24 . The method of claim 20 , wherein the therapeutically-effective amount of the at least one N-acylethanolamine or salt thereof is about 800 mg.
25 . The method of claim 20 , wherein the at least one N-acylethanolamine is chosen from N-palmitoylethanolamine (PEA), Me-Palmitoylethanolamide (Me-PEA), palmitoylcyclohexamide, palmitoylbutylamide, palmitoylisopropylamide, oleoylethanolamine (OEA), palmitoylisopropylamide (PIA), salts thereof, and any combination thereof.
26 . The method of claim 20 , wherein the at least one N-acylethanolamine is PEA or salt thereof.
27 . The method of claim 20 , wherein the derivative of 4-Aminophenol is paracetamol or a salt thereof and the N-acylethanolamine is PEA or a salt thereof.
28 . The method of claim 27 , wherein the derivative of 4-Aminophenol and N-acylethanolamine are administered as a mixture comprising about 0.5 mg to about 4000 mg of the paracetamol or salt thereof and about 50 mg to about 5000 mg of the PEA or salt thereof.
29 . The method of claim 20 , wherein the derivative of 4-Aminophenol and N-acylethanolamine are formulated for systemic administration.
30 . The method of claim 20 , wherein the derivative of 4-Aminophenol and N-acylethanolamine are formulated for oral, vaginal, rectal, oral mucosal, nasal, sublingual, inhalational, topical, parenteral, intravenous, intramuscular, or subcutaneous administration.
31 . (canceled)
32 . The method of claim 20 , wherein the derivative of 4-Aminophenol and N-acylethanolamine are formulated as a solution or as a suppository.
33 . The method of claim 20 , wherein at least one side-effect associated with paracetamol consumption is prevented or treated.
34 . The method of claim 20 , wherein the derivative of 4-Aminophenol and N-acylethanolamine are orally administered.
35 . The method of claim 20 , wherein the derivative of 4-Aminophenol and N-acylethanolamine are administered daily.
36 . The method of claim 20 , wherein the derivative of 4-Aminophenol and N-acylethanolamine are comprised in the same pharmaceutical composition.
37 . A kit for the treatment of pain or fever comprising:
a pharmaceutical composition comprising a therapeutically-effective amount of at least one derivative of 4-Aminophenol or a salt thereof; and
a pharmaceutical composition comprising a therapeutically-effective amount of at least one N-acylethanolamine or a salt thereof.